Biberach, Germany

Klaus Daneck

USPTO Granted Patents = 2 


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Biberach, DE (2018)
  • Biberach an der Riss, DE (2018)

Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Klaus Daneck: Innovator in Veterinary Medicine

Introduction

Klaus Daneck is a notable inventor based in Biberach, Germany. He has made significant contributions to the field of veterinary medicine, particularly through his innovative formulations of meloxicam solutions. With a total of 2 patents, his work focuses on improving the treatment options available for various ailments in mammals.

Latest Patents

Daneck's latest patents include highly concentrated stable meloxicam solutions. These aqueous cyclodextrin-free solutions are designed for administration by oral or parenteral routes. They contain a pharmacologically acceptable meloxicam salt of an organic or inorganic base, along with one or more suitable excipients. The content of dissolved meloxicam salt exceeds 10 mg/mL, and the formulation boasts a shelf-life of up to 24 months or more. This solution is particularly beneficial for treating mammals suffering from pain, inflammation, fever, acute mastitis, diarrhea, lameness, locomotor deficiency, or respiratory illness.

Career Highlights

Klaus Daneck is currently associated with Boehringer Ingelheim Vetmedica GmbH, where he continues to develop innovative solutions for veterinary care. His expertise in formulating stable drug solutions has positioned him as a key player in the industry.

Collaborations

Daneck has collaborated with notable colleagues such as Stefan Henke and Bernd Kruss. Their combined efforts contribute to advancing veterinary medicine through innovative research and development.

Conclusion

Klaus Daneck's contributions to veterinary medicine through his patented innovations highlight his commitment to improving animal health. His work continues to pave the way for more effective treatments in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…